What Are Glycans? The Key to Your Biological Age

Every cell in your body is coated in a layer of complex sugars. Not the kind that spikes your blood glucose — these are structural, information-dense molecules called glycans, and they have been quietly orchestrating your immune system, regulating inflammation, and signaling your biological age for your entire life. Most people have never heard of them. That gap between their biological importance and their public profile is exactly what GlycanAge was built to close.

Glycans are not a niche curiosity. They are, as Prof. Gordan Lauc, co-founder of GlycanAge, has described them, the intermediate layer of biology that sits between genes, which never change, and fast-moving metabolites like glucose, which fluctuate hourly. Understanding what glycans are, what they do, and why measuring them gives you a more accurate picture of how you are biologically aging than almost any other biomarker available today is the foundation of everything GlycanAge measures.

The science is rigorous. The implications are practical. Glycans are not just sugars — they are the most information-rich, lifestyle-responsive, and clinically relevant aging signal we can currently measure.

What Are Glycans, and Why Do They Matter?

Glycosylation vs Glycation: A Critical Distinction

Glycans are carbohydrate-based polymers (chains of sugar molecules) that exist on the surface of virtually every cell in the human body. They are not free-floating sugars, and they are not the same as the glycation measured by HbA1c in diabetes management. Glycation is a random, non-enzymatic process in which free sugars attach to proteins and damage their function. Glycosylation, the process that produces glycans, is the opposite: a precise, enzymatically controlled post-translational modification that gives proteins their functional identity.

The distinction matters because it reframes what glycans actually are. They are not a byproduct of sugar metabolism. They are active signalling molecules, built deliberately by the body to regulate how proteins behave. Most proteins in the human body are, in fact, glycoproteins (proteins with glycans attached). Without those glycans, the proteins cannot function. One accessible illustration: your blood type is determined not by your DNA sequence alone, but by the specific glycans on the surface of your red blood cells. The glycan is the functional layer that makes the protein meaningful in context.

Glycans as Molecular Antennas

Glycans also serve as the primary medium for cell-to-cell communication. They act as molecular antennas, reading and transmitting signals between cells, between the immune system and tissues, and between the body's internal environment and external stressors like diet, stress, and hormonal change. This communication role is why glycans carry so much biological information: they integrate genetic programming, epigenetic history, and real-time lifestyle inputs into a single, measurable molecular signal.

How Glycans on IgG Antibodies Reveal Your Biological Age

The Anti-Inflammatory to Pro-Inflammatory Shift

The specific glycans GlycanAge measures are those attached to Immunoglobulin G (IgG), the central protein of the adaptive immune system. IgG antibodies are the body's primary long-term immune responders, and the glycans on their surface determine whether an immune interaction produces an anti-inflammatory or a pro-inflammatory outcome. The distinction of pro- versus anti-inflammatory is the core of what biological age testing through glycans actually measures.

The structural logic is straightforward. A young, healthy IgG glycan carries two galactose molecules and two sialic acid molecules attached to its branching structure. This configuration is anti-inflammatory. As the body ages, galactosylation (the attachment of galactose) declines. Shorter, less decorated glycans accumulate. These agalactosylated glycans are pro-inflammatory. The longer the glycan structure, the more anti-inflammatory it tends to act; the shorter and more stripped-back the structure, the more it drives chronic inflammation.

"Changing a single monosaccharide in a glycan can completely convert the function of an immunoglobulin from pro-inflammatory into anti-inflammatory. The simple addition or removal of a sugar residue at the core of the glycan can activate or prevent antibody-dependent cellular cytotoxicity — making both monoclonal drugs and our native antibodies up to a hundred times more or less efficient."

— Prof. Gordan Lauc, Chief Scientific Officer, GlycanAge; Professor of Biochemistry and Molecular Biology, University of Zagreb

Measuring 29 Glycan Structures

GlycanAge measures 29 distinct glycan structures on IgG from a single blood sample. The ratio of pro-inflammatory to anti-inflammatory glycans across those 29 structures produces a biological age score. This number reflects not how many years you have lived, but how fast your immune system is aging. This is what makes GlycanAge a measure of inflammaging: the chronic, low-grade, sterile inflammation driven by the aging immune system that accelerates biological aging and underlies most age-related diseases.

The Limitations of Standard Inflammatory Markers

Standard inflammatory markers, such as hsCRP, TNF-alpha, IL-6, and the neutrophil-to-lymphocyte ratio, are useful for detecting acute inflammation, but they are poorly suited to measuring the chronic, low-grade inflammatory state that drives aging. They fluctuate with acute infection, are skewed by transient events, and do not reliably capture the sterile inflammaging process. IgG glycosylation captures something these markers miss: the underlying inflammatory tone of the immune system, integrated over time.

What the Research Shows

Research on more than 5,000 individuals across four European populations has shown that IgG glycans explain up to 58% of the variation in chronological age, with cross-population validation ranging from 41% to 50%, outperforming other established biological age biomarkers. IgG glycan heritability varies across individual glycan structures, with the majority showing a genetic contribution of 50% or higher. That means at least half of the variation in most glycan traits is shaped by environment, lifestyle, and accumulated biological history. This is the space where intervention becomes possible and where GlycanAge becomes actionable.

"Normally we either use things which are measuring some metabolites, enzymes, glucose concentration, and so on, which change extremely quickly, or we look at genes, which don't change at all. We are missing some kind of intermediate phenotypes between these day-to-day altering molecules and genes which do not change — and these are the glycans."

— Prof. Gordan Lauc, Chief Scientific Officer, GlycanAge; Professor of Biochemistry and Molecular Biology, University of Zagreb

What Makes Glycans Uniquely Useful as a Biological Age Biomarker

Three properties set IgG glycosylation apart from other aging biomarkers: stability in the absence of change, responsiveness to genuine biological change, and the depth of information encoded in the glycan signal.

Stability means that if you measure someone's GlycanAge today and again in two months without any lifestyle or medical intervention, the result will be essentially the same. This is not a trivial property. As explored in detail in our comparison of epigenetic and glycan aging clocks, DNA methylation-based clocks can vary by up to 10 years between repeat measurements in the same individual, even without any intervention. That level of analytical noise makes it difficult to distinguish a real biological shift from measurement artifacts. GlycanAge's reproducibility means that when a result changes, the change is meaningful.

Responsiveness means that when genuine biological change occurs, through lifestyle modification, medical intervention, or disease progression, glycans reflect it within three to six months. This is fast enough to be actionable within a clinical or personal health tracking context, and slow enough to filter out the daily fluctuations that make standard blood panels unreliable as aging signals. Prof. Lauc has tracked his own GlycanAge for nearly a decade and observed directly how dietary changes, weight shifts, and periods of stress move the number in predictable directions.

"If I change to a healthier lifestyle, it actually goes down. In a difficult period, it can accelerate — and in a year I could lose ten years of my GlycanAge."

— Prof. Gordan Lauc, Chief Scientific Officer, GlycanAge; Professor of Biochemistry and Molecular Biology, University of Zagreb

Information depth refers to the fact that glycans integrate genetic, epigenetic, and environmental inputs simultaneously. A single glycan profile encodes information about your genetic predisposition to inflammation, the cumulative effect of your lifestyle history, and your current inflammatory state. No other single biomarker currently available captures all three layers in one measurement.

Glycans Are Modifiable and That Changes Everything

This means you can measure whether your interventions, such as dietary changes, exercise protocols, supplements, stress management, are actually working at the molecular level, not just on the scale or in the mirror. It also means you have a validated, reproducible biomarker to baseline before an intervention and retest three to six months later to confirm a biological response. The question stops being "am I doing the right things?" and becomes "is my biology responding?"

The research evidence on what specifically moves glycan profiles is substantial. Key findings include:

Diet and Weight: In overweight individuals, caloric restriction produces consistent anti-inflammatory improvements in IgG glycan profiles, with weight loss itself, rather than any specific diet type, identified as the primary driver. Research in patients undergoing bariatric surgery has documented reductions in biological age of more than a decade through improvements across multiple glycan indexes. Individual responses to different dietary approaches vary significantly, which is precisely why tracking biomarkers rather than following generic protocols is more effective.

Exercise: Moderate, regular physical activity reduces pro-inflammatory glycans and lowers biological age. Importantly, overtraining produces the opposite effect, as excessive exercise volume without adequate recovery elevates pro-inflammatory glycan structures, a pattern visible in the GlycanAge results of elite athletes and overworked executives alike.

Sleep and Stress: Chronic psychological stress and disrupted sleep are among the most reliably documented drivers of elevated biological age in glycan terms. A study of individuals with PTSD and trauma exposure found glycan-based biological age accelerated by an average of 15 years compared to low-stress controls. Elevated bisecting glycans, associated with stress physiology and circadian disruption, shift directionally toward a more anti-inflammatory profile with sustained recovery and improved sleep consistency.

Hormones: Estrogen directly regulates IgG glycosylation in both women and men. This is why glycan-based biological age tends to be lower in premenopausal women and rises sharply at menopause. Testosterone supplementation in men improves glycan profiles through its conversion to estrogen. The effects of estrogens on GlycanAge and the role of hormone tracking in clinical practice are documented across published research and clinical case studies.

What Glycan Changes Signal About Disease Risk

Glycan patterns do not only reflect biological age in aggregate, but they carry specific information about disease risk across multiple systems. GlycanAge's own research, drawing on over 100 published scientific papers, has established that glycan changes begin occurring six to ten years before a chronic disease is clinically diagnosed.

The glycan insights section of the GlycanAge report cross-references each patient's glycan index results against the patterns observed in specific disease populations. Current evidence covers the following areas:

Cardiovascular: IgG glycans show significant association with atherosclerosis, coronary artery disease, hypertension, myocardial infarction, ischemic stroke, and atrial fibrillation. One study achieved an AUC of 0.983 for predicting hypertension 6.3 years before diagnosis using a model combining IgG glycan traits with age, BMI, and blood pressure. Separate research published in Circulation Research demonstrated reproducible associations between IgG N-glycosylation profiles and future cardiovascular events across two independent cohorts.

Metabolic: Glycan profiles are significantly associated with type 2 diabetes and insulin resistance, with glycan changes detectable up to ten years before diagnosis in some studies, and prediction models consistently showing windows of six to seven years. When plasma glycan profiles are combined with validated metabolic risk scores, AUC values of up to 0.9 for type 2 diabetes prediction have been achieved, with glycan-only models reaching 0.77 to 0.78.

Autoimmune: Decreased IgG galactosylation was first reported in rheumatoid arthritis patients over 40 years ago. Since then, altered glycan patterns have been documented across rheumatoid arthritis, systemic lupus erythematosus, Crohn's disease, ulcerative colitis, and Sjögren's syndrome, in many cases preceding clinical diagnosis by years.

Respiratory: Glycan indexes are associated with COPD and broader respiratory stress patterns, with suboptimal Glycan Bisection linked to autonomic dysregulation and heightened environmental strain, including chronic exposure to airborne irritants.

It is important to note that glycan insights are for informational purposes only and should be triangulated with other clinical data. They cannot diagnose any condition. What they can do is surface an inflammatory signature that warrants closer clinical attention — often years before symptoms appear. More detail is available in the glycans, inflammation, and aging biology FAQ.

Understanding Your GlycanAge Report: The Five Glycan Indexes

A GlycanAge result is not a single number in isolation. The report returns five distinct glycan indexes, each reflecting a different structural property of the IgG glycome and carrying different clinical and biological meaning.

Primary Indexes: Calculating Biological Age

Primary indexes have a clear pro- or anti-inflammatory function and are used to calculate biological age:

• Glycan Shield (S): An anti-inflammatory index measuring the presence of sialic acid on IgG glycan structures. Higher Glycan Shield is associated with stronger immune regulation and a more protective inflammatory profile.

• Glycan Youth (G2): An anti-inflammatory index measuring the presence of two galactose molecules. This is one of the clearest markers of immune aging — Glycan Youth declines progressively with age and rises in response to effective anti-inflammatory interventions.

• Glycan Mature (G0): A pro-inflammatory index measuring the absence of galactose. As Glycan Mature rises, the immune system shifts toward a more inflammatory baseline. Elevated Glycan Mature combined with low Glycan Youth represents the classic pattern of accelerated immune aging.

Supportive Indexes: Narrowing Down the Picture

Supportive indexes help narrow down associations with specific disease types, genetic traits, and lifestyle patterns:

• Glycan Median (G1): Measures the presence of one galactose molecule. It contextualises the relationship between Glycan Youth and Glycan Mature and provides additional resolution on the inflammatory gradient.

• Glycan Bisection (B): Measures the presence of a bisecting GlcNAc modification. This index is particularly sensitive to stress physiology, autonomic dysregulation, sleep disruption, smoking, and chronic environmental strain. Optimal Glycan Bisection is associated with strong immune regulation; elevated Glycan Bisection signals heightened systemic stress.

Together, the five indexes give both the individual and their clinician a structured map of where biological aging is accelerating, what is likely driving it, and which interventions are most likely to produce a measurable response. See the provider report section for a full breakdown of what practitioners receive.

Putting Glycan Science Into Practice

The GlycanAge test requires four drops of blood from a finger-prick, collected at home and returned to the lab by pre-paid post. Results are delivered within two to three weeks via a personal dashboard, accompanied by a one-to-one interpretation call with a longevity specialist.

For individuals, the report gives a biological age alongside the five glycan indexes — a molecular readout of how the immune system is aging, grounded in 30 years of research, more than 350 published papers, and the analysis of over 300,000 glycan samples.

For practitioners, the workflow is straightforward: baseline before an intervention, retest at three to six months, and use the change in biological age and glycan indexes to guide the next clinical decision. This protocol is validated across HRT for menopause, cardiovascular risk management, metabolic health, and immune aging in high-stress individuals.

The Sugars That Science Has Been Waiting For

Glycans have been present in every cell of your body since before you were born. The science to measure them reliably, interpret them clinically, and use them to track biological aging has taken decades to develop, and it is now commercially available in an at-home test that returns results in under three weeks.

The core insight is simple even if the biology is not: the glycans on your IgG antibodies determine whether your immune system is running hot or cool, whether chronic inflammation is accelerating your biological age or being held in check, and whether the interventions you are making are working at the molecular level. That information was previously inaccessible outside specialist research settings. It no longer is.

If you are ready to measure your biological age through the lens of your immune system — and to understand what your glycans are actually telling you — order a GlycanAge test kit and book your one-to-one result interpretation call. View pricing and plans to find the option that fits your goals. If you are a practitioner looking to integrate glycan biomarker testing into your clinical workflow, the Healthcare Providers page outlines how GlycanAge fits into longevity, menopause, and functional medicine practice.

Order your GlycanAge test → Shop Now

For clinicians and practitioners → Explore Healthcare Provider Options

Frequently Asked Questions About Glycans and Biological Age

What are glycans, in simple terms?

Glycans are chains of sugar molecules that coat the surface of nearly every cell in your body. Unlike dietary sugars, glycans are not a fuel source, but precision-built signalling molecules that regulate how proteins function, how immune cells communicate, and how your body manages inflammation. They are the functional layer that sits between your fixed DNA and your fast-changing metabolites.

Are glycans the same as blood sugar?

No. Blood sugar, or glucose, is a simple monosaccharide used for cellular energy and measured by standard tests like HbA1c. Glycans are complex, multi-branched carbohydrate structures that are enzymatically attached to proteins in a process called glycosylation. This is entirely distinct from glycation, which is the damaging, non-enzymatic attachment of free sugars to proteins associated with diabetes complications. The glycation vs glycosylation distinction is one of the most important concepts in understanding why glycan measurement is different from standard metabolic testing.

Why do glycans matter for aging?

As you age, the glycans attached to your IgG antibodies change in predictable ways: anti-inflammatory, well-decorated glycan structures give way to shorter, pro-inflammatory forms. This shift fuels chronic, low-grade inflammation, known as inflammaging, which underlies most age-related diseases, including cardiovascular disease, type 2 diabetes, and autoimmune conditions. Measuring this shift gives you a direct readout of how fast your immune system is biologically aging.

Can glycans be changed?

Yes, and this is what makes glycan testing clinically useful rather than just descriptive. Glycan profiles respond to diet, exercise, sleep quality, stress management, weight loss, and medical interventions including hormone replacement therapy. Research shows that meaningful changes in biological age, as measured by glycans, can occur within three to six months of a sustained intervention. The approximately 45% of glycan variation that is environmentally driven is the space where lifestyle and clinical intervention operate.

How does the GlycanAge test work?

The test requires four drops of blood from a finger-prick, collected at home using a kit sent to your address. The sample is returned to the lab by pre-paid post. Results are processed within two to three weeks and delivered through a personal dashboard, with a one-to-one interpretation call with a longevity specialist included. The report shows your biological age alongside five distinct glycan indexes that break down the specific inflammatory patterns driving your result.

External Sources

• https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2014.00145/full — Lauc G, Krištić J, Vučković F. "Glycans — the third revolution in evolution." Frontiers in Genetics. 2014.

• https://www.nature.com/articles/s41574-018-0059-4 — Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A. "Inflammaging: a new immune–metabolic viewpoint for age-related diseases." Nature Reviews Endocrinology. 2018.

• https://www.ncbi.nlm.nih.gov/books/NBK579918/ — NIH National Library of Medicine. "Essentials of Glycobiology."

• https://www.niddk.nih.gov/health-information/diagnostic-tests/a1c-test — NIH National Institute of Diabetes and Digestive and Kidney Diseases. "The A1C Test and Diabetes."

• https://academic.oup.com/biomedgerontology/article/69/7/779/662651 — Krištić J, Vučković F, Menni C, et al. "Glycans Are a Novel Biomarker of Chronological and Biological Ages." The Journals of Gerontology: Series A. 2014;69(7):779–89.

• https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0082558 — Menni C, Keser T, Mangino M, et al. "Glycosylation of Immunoglobulin G: Role of Genetic and Epigenetic Influences." PLOS ONE. 2013;8(12):e82558.